Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2010
06/16/2010EP2195006A2 Use of a peptide and an analgesic pharmaceutical agent
06/16/2010EP2195004A1 Method of inhibiting clostridium difficile by administration of oritavancin
06/16/2010EP2195003A1 Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
06/16/2010EP2195001A1 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits
06/16/2010EP2194987A2 Novel stat3 pathway inhibitors and cancer stem cell inhibitors
06/16/2010EP2194976A1 Hepatitis c antiviral compositions and methods
06/16/2010EP2194970A2 Enhancement of the efficacy of therapeutic proteins
06/16/2010EP2194782A1 Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell 1
06/16/2010EP1645566B1 Analogs of parathyroid hormone
06/16/2010EP1611153B1 Antitumor effect of mutant bik
06/16/2010CN1997361B Antitumor agent
06/16/2010CN1913912B Pharmaceutical compositions and methods for insulin treatment
06/16/2010CN1894276B HCV NS3-NS4A protease resistance mutants
06/16/2010CN1867582B Process for preparing an alpha-1-antitrypsin solution
06/16/2010CN1857232B Biodegradable nano magnetic capsule loading medicine and its preparing process
06/16/2010CN1812997B Pharmaceutical composition outside stomach intestine containing somatostatin analogue
06/16/2010CN1802384B Method for synthesis of perindopril and its pharmaceutically acceptable salts
06/16/2010CN1787829B Composition against infection with rotavirus and process for producing the same
06/16/2010CN1771040B Remedy for diabetes.
06/16/2010CN1653079B Intercalator containing pseudonucleotide(s)
06/16/2010CN1634981B A group of antibiotic peptides, method for preparation and use thereof
06/16/2010CN1518558B Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament
06/16/2010CN1517126B Drug compastion with thrombolysis, anti-inflammatory and cell protective function
06/16/2010CN1500095B Polymer conjugates of neublastin and methods of using ssame
06/16/2010CN1162978B Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
06/16/2010CN101743308A Lipase variants for pharmaceutical use
06/16/2010CN101743252A protease stabilized, pegylated insulin analogues
06/16/2010CN101743251A Peptides with anitfungal activity
06/16/2010CN101743021A Stabilized suspension
06/16/2010CN101743018A Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
06/16/2010CN101743017A Modified human factor VII/VIIa and pharmaceutical composition containing same
06/16/2010CN101743016A Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis
06/16/2010CN101743015A The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
06/16/2010CN101743014A oligopeptide for enhancing osteointegration and osteogenesis
06/16/2010CN101743013A Specific therapy and medicament using integrin ligands for treating cancer
06/16/2010CN101743005A Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine
06/16/2010CN101743004A Therapeutic compositions and the use thereof
06/16/2010CN101736065A Method for preparing polypeptide by beer sediment
06/16/2010CN101736064A Process for preparing immune reinforcement peptide for enzymolysis on ocean shell and application thereof
06/16/2010CN101736008A Method for preparing genetic engineering N-acetylated thymosin alpha1
06/16/2010CN101735991A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
06/16/2010CN101735315A AMP-18 antigen polypeptide and application in preparing medicament for treating tumor
06/16/2010CN101735314A Osteopontin and purpose of protecting liver thereof
06/16/2010CN101735307A Platelet envelope glycoprotein oligopeptide or trim/derivate thereof and application thereof
06/16/2010CN101735306A Anti-inflammatory peptide with membrane penetration effect
06/16/2010CN101732717A Ttk in diagnosis and as a therapeutic target in cancer
06/16/2010CN101732714A Manchette binding protein and effects thereof during spermiogenesis
06/16/2010CN101732703A Composition for antagonizing pyretic effect of endotoxin in vaccine on livestock and application thereof
06/16/2010CN101732700A Health-care wine and preparation method thereof
06/16/2010CN101732699A Cyclopeptide nanotube medicinal composition and application thereof
06/16/2010CN101732698A Traditional Chinese medicine preparation with effect of lowering blood sugar, preparation method and application thereof
06/16/2010CN101732697A Compound frozen ossotide preparation
06/16/2010CN101732696A Method for preparing composition of peptide, calcium and magnesium
06/16/2010CN101732695A Compound of brain protein hydrolyzate and maleic acid and method for preparing same
06/16/2010CN101732329A Combined medicine with synergistic action for treating T cell lymphomata and application thereof
06/16/2010CN101732284A Nano and micro package of interferon and releasing thereof
06/16/2010CN101732245A Two-phase isophane zinc recombinant human insulin injection and preparation method thereof
06/16/2010CN101731178A Breeding environment regulator, preparation method and application thereof in livestock and poultry breeding industry
06/16/2010CN101121019B Use of division deficient protein 3
06/16/2010CN101100664B Method for preparing recombinant canine alpha-type interferon
06/16/2010CN101041066B The application of r-sHSA for treating chronic liver disease
06/16/2010CN101027074B Total enteral nutritious composition
06/16/2010CN101001620B Use of alpha-ketoglutarate and related compounds for lowering plasma lipids
06/15/2010US7737264 Oligomeric compounds for the modulation HIF-1α expression
06/15/2010US7737256 anti-HIV action of uPAR-activators or activated uPAR molecules; diagnosis of cancer, AIDS and inflammatory diseases; treatment of septic shock, rheumatoid arthritis, Crohn's disease, and chronic arthritis
06/15/2010US7737252 Peptide-based compounds
06/15/2010US7737251 conjugates comprising blood proteins covalently coupled to a gastrointestinal tissue growth promoter derivatives, having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders
06/15/2010US7737162 Viral inhibitors
06/15/2010US7737120 Methods for the specific preparation of lysobactin fragments
06/15/2010US7737119 For therapy of cutaneous manifestations of aging and/or its use in order to act against cellulite
06/15/2010US7737118 Alternating intrathecal administration to the mammal of a pharmaceutically effective dose of opioid receptor agonist for first period of time, and dose of at least one opioid receptor-like receptor 1 agonist for a second period of time
06/15/2010US7737116 Modified and stabilized GDF propeptides and uses thereof
06/15/2010US7737115 HGF beta chain variants
06/15/2010US7737114 macrocyclic depsipeptides, for use as anticancer agents and an inhibitors of protein synthesis, cell growth, and tumorigenesis and as enhancers of apoptosis
06/15/2010US7737113 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others
06/15/2010US7737112 comprising a practically insoluble peptide epoxy ketone proteasome inhibitor or pharmaceutically acceptable salt thereof and a substituted cyclodextrin selected from hydroxypropyl beta-cyclodextrin and sulfobutyl ether beta-cyclodextrin; enhanced solubility
06/15/2010US7737111 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
06/15/2010US7737110 increasing ratio of wild type IKBKAP mRNA to misspliced IKBKAP mRNA in cells where misspliced IKBKAP mRNA is transcribed from mutant IKBKAP gene expressing wild type and misspliced IKBKAP mRNA by contacting cells possessing mutant IKBKAP gene with kinetin to increase ratio of wild type to misspliced mRNA
06/15/2010US7737109 Obesity controlling method
06/15/2010US7737108 Enhanced transport using membrane disruptive agents
06/15/2010US7736899 Cells and method for producing proteins comprising an unconventional amino acid
06/15/2010US7736895 Altering differentiated state of somatic cells via adjusting gene expression patterns; removing suppressor protein from chromatin masses; reprogramming differentiated cells
06/15/2010US7736874 Relicating preferential nucleotide sequences using mixture comprising polymerase-amplified nucleic acid having a 5' overhang, a vector having a 3' overhang and an antibody that binds polymerase; improving exogenous gene expression
06/15/2010US7736873 An isolated nucleic acid molecule comprising a nucleotide sequence which encodes the polypeptide comprising the outer membrane protein antigens of gramnegative bacteria, which can be used to prevent and treat gramnegative bacteria infection in mammals, such as humans; immunology; vaccines
06/15/2010US7736845 soaking the tissue in a cold stabilizing first solution, then in a polyether, salt, hydrogen peroxide and phosphate buffer second solution, in an alcohol and water to remove residues of the first solution and in a third solution of an antiinflammatory agent, an anticoagulant, alcohol and water
06/15/2010US7736668 A delayed delivery drug dose to a fluid environment consists of a dose of drug, a second formulation with imbibes fluid and expands, a wall that confines both and permeable to the passage of fluid, a subcoat of hydroxyalkyl cellulose
06/15/2010US7736667 Release rate constant over time for several hours within the early part of the release profile, confining the release to the upper GI tract; shell remains intact during entire period of drug release
06/15/2010US7736659 Clostridial toxin derivatives and methods for treating pain
06/15/2010US7736657 Fusion constructs containing active sections on TNF ligands
06/15/2010US7736655 Neuroprotectants; angoigenesis inhibitors; transcription factors; host cells
06/15/2010US7736654 Proteins, polynucleotides, antibodies, transgenic animals, hybridoma; humoral or cellular immune response; pancreatic
06/15/2010US7736653 Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier
06/15/2010US7736652 Comprises immunoglobulin-immunostimulant fusion protein for use in preventing and treating infections, cancer and autoimmune disorders; genetic vaccination; gene therapy
06/15/2010US7736649 preventing the viral entry process into target cells, by inhibiting the binding of viral surface glycoprotein to cell surface CD4, to fusion coreceptors CCR5 chemokine receptors and the transient conformation fusion intermediate that ultimately folds into a conformation capable of mediating fusion
06/15/2010US7736646 Methods for modulating angiogenesis with apelin compositions
06/15/2010US7736643 A mutant hydrolase protein of Candida comprising an amino acid sequence, where the #219 leucine is replaced by a hydrophilic amino acid selected from glutamine, histidine, arginine, lysine, serine, threonine, aspartic acid and glutamic acid, used in the food and detergent industry
06/15/2010US7736640 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression
06/15/2010US7736639 Using water-soluble polymer conjugated interleukin-18 as therapeutic in treatment and prevention of cell proliferative disorders
06/15/2010US7736638 Interleukin-15 antagonist peptide
06/15/2010US7736637 administering to a cancer patient a soluble tumor necrosis factor related apoptosis inducing ligand (TRAIL) polypeptide, selected from the extracellular domain of human TRAIL or fragment thereof, in the form of an oligomer; treatment of leukemia, melanoma or lymphoma
1 ... 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 ... 3163